BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND OLIG2, OLIGO2, 10215, ENSG00000205927, BHLHB1, RACK17, PRKCBP2 AND Treatment
58 results:

  • 1. Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo.
    Radin DP; Shifman S; Outhwaite IR; Sharma A; Bases R; Seeliger MA; Tsirka SE
    J Pharmacol Exp Ther; 2024 Mar; 389(1):51-60. PubMed ID: 38296645
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Deciphering the Action of Neuraminidase in Glioblastoma Models.
    Baeza-Kallee N; Bergès R; Hein V; Cabaret S; Garcia J; Gros A; Tabouret E; Tchoghandjian A; Colin C; Figarella-Branger D
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511403
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Oligodendrocyte Transcription Factor 2 as a Potential Prognostic Biomarker of Glioblastoma: Kaplan-Meier Analysis and the Development of a Binary Predictive Model Based on Visually Accessible Rembrandt Image and Magnetic Resonance Imaging Radiomic Features.
    Mei N; Lu Y; Yang S; Jiang S; Ruan Z; Wang D; Liu X; Ying Y; Li X; Yin B
    J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):650-658. PubMed ID: 37380154
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.
    Martínez-Bosch N; Vilariño N; Alameda F; Mojal S; Arumí-Uria M; Carrato C; Aldecoa I; Ribalta T; Vidal N; Bellosillo B; Menéndez S; Del Barco S; Gallego O; Pineda E; López-Martos R; Hernández A; Mesia C; Esteve-Codina A; de la Iglesia N; Balañá C; Martínez-García M; Navarro P
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980184
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood-brain barrier and treatment strategies.
    Chhichholiya Y; Ruthuparna M; Velagaleti H; Munshi A
    Clin Transl Oncol; 2023 May; 25(5):1218-1241. PubMed ID: 36897508
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MN1 altered astroblastoma with APC and LRP1B gene mutations: a unique variant in the cervical spine of a pediatric patient.
    Mugge L; Dang DD; Stabingas K; Keating G; Rossi C; Keating R
    Childs Nerv Syst; 2023 May; 39(5):1309-1315. PubMed ID: 36648513
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities.
    Verma R; Chen X; Xin D; Luo Z; Ogurek S; Xin M; Rao R; Berry K; Lu QR
    Cancer Res; 2023 Mar; 83(6):890-905. PubMed ID: 36634201
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The spectrum of morphological findings in pediatric central nervous system MN1-fusion-positive neuroepithelial tumors.
    Lubieniecki F; Vazquez V; Lamas GS; Camarero S; Nuñez FJ; Baroni L; Schüller U; Alderete D
    Childs Nerv Syst; 2023 Feb; 39(2):379-386. PubMed ID: 36534132
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
    Keck MK; Sill M; Wittmann A; Joshi P; Stichel D; Beck P; Okonechnikow K; Sievers P; Wefers AK; Roncaroli F; Avula S; McCabe MG; Hayden JT; Wesseling P; Øra I; Nistér M; Kranendonk MEG; Tops BBJ; Zapotocky M; Zamecnik J; Vasiljevic A; Fenouil T; Meyronet D; von Hoff K; Schüller U; Loiseau H; Figarella-Branger D; Kramm CM; Sturm D; Scheie D; Rauramaa T; Pesola J; Gojo J; Haberler C; Brandner S; Jacques T; Sexton Oates A; Saffery R; Koscielniak E; Baker SJ; Yip S; Snuderl M; Ud Din N; Samuel D; Schramm K; Blattner-Johnson M; Selt F; Ecker J; Milde T; von Deimling A; Korshunov A; Perry A; Pfister SM; Sahm F; Solomon DA; Jones DTW
    Acta Neuropathol; 2023 Jan; 145(1):49-69. PubMed ID: 36437415
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Recurrent high-grade astroblastoma with
    Sun D; Liu J; Xiao L; Guan H
    Clin Neuropathol; 2023; 42(1):30-39. PubMed ID: 36366964
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Correlation of Clinicopathological Factors with brain Tumor-Related Epilepsy in Glioma.
    Wang Z; Yang W; Wang Y; Aili Y; Wang Z; Wang Q; Jiang S; Zhang G; Zhang J; Li B
    Dis Markers; 2022; 2022():4918294. PubMed ID: 36246555
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Diffuse leptomeningeal glioneuronal tumor in an 8-year-old girl: case report and review of the literature.
    Cambruzzi E; Medeiros MS; Cardoso CE; Silva GAG; Schlotte K; Kus WP
    Childs Nerv Syst; 2023 Jan; 39(1):301-305. PubMed ID: 35922601
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. CNS tumor with BCOR internal tandem duplication: Clinicopathologic, molecular characteristics and prognosis factors.
    Wang R; Guan W; Qiao M; Zhang Y; Zhang M; Wang K; Wang Y; Wang L
    Pathol Res Pract; 2022 Aug; 236():153995. PubMed ID: 35809497
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Diffuse midline gliomas with H3K27 alteration in children: a clinicopathological analysis of forty-one cases].
    Li J; Ma YY; Feng J; Zhao D; Ding F; Tian L; Chen R; Zhao R
    Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):319-325. PubMed ID: 35359043
    [No Abstract]    [Full Text] [Related]  

  • 15. The Epigenetic Regulation of olig2 by Histone Demethylase KDM6B in Glioma Cells.
    Sui A; Han B; Ren W; He W; Gao C; Han X; Liu S; Zhang Y; Qi X; Guo X
    J Mol Neurosci; 2022 May; 72(5):939-946. PubMed ID: 35132566
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors.
    Knudsen AM; Halle B; Cédile O; Burton M; Baun C; Thisgaard H; Anand A; Hubert C; Thomassen M; Michaelsen SR; Olsen BB; Dahlrot RH; Bjerkvig R; Lathia JD; Kristensen BW
    Neuro Oncol; 2022 Jul; 24(7):1074-1087. PubMed ID: 34964899
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Gene clusters based on olig2 and CD276 could distinguish molecular profiling in glioblastoma.
    Fu M; Zhang J; Li W; He S; Zhang J; Tennant D; Hua W; Mao Y
    J Transl Med; 2021 Sep; 19(1):404. PubMed ID: 34565408
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.
    Lee SH; Kwon HJ; Park S; Kim CI; Ryu H; Kim SS; Park JB; Kwon JT
    PLoS One; 2021; 16(9):e0257375. PubMed ID: 34516577
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Overview and recent advances in the targeting of medulloblastoma cancer stem cells.
    Paul MR; Zage PE
    Expert Rev Anticancer Ther; 2021 Sep; 21(9):957-974. PubMed ID: 34047251
    [No Abstract]    [Full Text] [Related]  

  • 20. Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy.
    Carrato C; Alameda F; Esteve-Codina A; Pineda E; Arpí O; Martinez-García M; Mallo M; Gut M; Lopez-Martos R; Barco SD; Ribalta T; Capellades J; Puig J; Gallego O; Mesia C; Muñoz-Marmol AM; Archilla I; Arumí M; Blanc JM; Bellosillo B; Menendez S; Esteve A; Bagué S; Hernandez A; Craven-Bartle J; Fuentes R; Vidal N; Aldecoa I; Iglesia N; Balana C
    Clin Cancer Res; 2020 Dec; 26(24):6600-6609. PubMed ID: 32998960
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.